“Shedding” low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients - 18/08/23
Doi : 10.1016/j.jaad.2023.05.045
Rhiannon C. Miller, BA a, Sajjad Abedian, MS b, Shari R. Lipner, MD, PhD a, ⁎ 
a Department of Dermatology, Weill Cornell Medicine, New York, New York
b Information Technologies & Services Department, Weill Cornell Medicine, New York, New York
∗Correspondence to: Shari R. Lipner, MD, PhD, Department of Dermatology, Weill Cornell Medicine, 1305 York Ave, New York, NY 10021Department of DermatologyWeill Cornell Medicine1305 York AveNew YorkNY10021
Key words : anemia, hair loss, iron, laboratory testing, telogen effluvium, testosterone, thyroid, zinc
| Funding sources: None. |
|
| IRB approval status: This study was reviewed and approved by the Weill Cornell Medicine Institutional Review Board (IRB), WCM IRB #19-11021049. |
© 2023
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 3
P. 623-626 - septembre 2023 Retour au numéro
Article précédent
- Online risk calculator and nomogram for predicting sentinel lymph node positivity in Merkel cell carcinoma
- Nolan J. Maloney, Sumaira Z. Aasi, Nour Kibbi, Kelsey E. Hirotsu, Lisa C. Zaba
- Defining “Access to Care” for dermatology at academic medical institutions
- Bianca Patel, Travis W. Blalock
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?